Free Trial

Bellerophon Therapeutics (BLPH) SEC Filings & 10K Form

Bellerophon Therapeutics logo
$0.04
0.00 (0.00%)
(As of 09:30 AM ET)

Recent Bellerophon Therapeutics SEC Filings

DateFilerForm TypeView
03/01/2024
9:04 AM
Bellerophon Therapeutics (Subject)
Nelson Michael Aaron (Filed by)
Form SCHEDULE 13G
02/12/2024
2:44 PM
Bellerophon Therapeutics (Filer)
Form DEFA14A
02/12/2024
11:39 AM
Bellerophon Therapeutics (Filer)
Form DEFA14A
01/30/2024
8:29 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2024
2:21 PM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
12:49 PM
Bellerophon Therapeutics (Filer)
Form DEFA14A
12/27/2023
8:01 AM
Bellerophon Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
12/12/2023
3:10 PM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
3:05 PM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:31 PM
Bellerophon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
3:30 PM
Bellerophon Therapeutics (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BLPH) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners